Aris Water Solutions (NYSE:ARIS) Hits New 52-Week High at $17.95

Oramed Pharmaceuticals (NASDAQ:ORMP) Posts Earnings Results, Misses Expectations By $0.01 EPS



Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01).



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *